Patient Guide to Support Services

2019 Patient Guide to Support Services

Index sorted by Drug, Company, and Foundations and Nonprofit/Government Organizations Read More ›

Recent advancements in cancer treatments have revolutionized cancer care. The use of genetic mutations to guide therapy, and continued innovations in immunotherapies, targeted drugs, radiation, and chemotherapy have improved patients’ health outcomes and quality of life. Read More ›

It is no secret that the cost of cancer drugs continues to escalate, resulting in significant financial burden for patients. And when it comes to cancer, the financial stress is compounded by the enormous emotional stress associated with a cancer diagnosis, which can affect survival. Read More ›

AbbVie, together with Genentech, has developed and is marketing the oncology drug Venclexta (venetoclax). Venclexta is indicated for patients with chronic lymphocytic leukemia and 17p deletion who have received at least 1 treatment, and for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma with or without 17p deletion after 1 treatment. Read More ›

Agios Pharmaceuticals offers the myAgios Patient Support Services, a program that provides a suite of support services for patients who have been prescribed Tibsovo (ivosidenib). Read More ›

Rigel Pharmaceuticals offers the Rigel OneCare patient support program, which provides several financial assistance options and support services for patients who have been prescribed Tavalisse (fostamatinib disodium hexahydrate) tablets. Read More ›

Jazz Pharmaceuticals, through its JumpStart Program, offers patients support for its hematology/oncology drugs—Defitelio (defibrotide sodium), Erwinaze (asparaginase Erwinia chrysanthemi), and Vyxeos. Read More ›

LexCares is a comprehensive patient support services program offered by Lexicon to assist patients who are prescribed Xermelo (telotristat ethyl). Read More ›

Eli Lilly and Company, through Lilly Oncology, offers financial assistance to qualified patients who are prescribed oncology medications and who need help in paying for their cancer medications. Read More ›

Merck Helps offers a full suite of support services that facilitate access to Merck’s drugs for eligible patients who are unable to afford their Merck medications, regardless of their insurance status. Read More ›

Novartis Oncology provides a full range of patient assistance programs and support services through Novartis Patient Assistance Now Oncology (PANO). This comprehensive support program provides support and resources for patients and providers through the Novartis Universal Co-Pay Program, Novartis Patient Assistance Foundation. Read More ›

Pfizer Oncology Together is a patient support program that provides patients and providers access to reimbursement services, financial assistance services, and personalized patient support offerings. Patients may be eligible for different support service options based on their needs and on the Pfizer oncology medication they are prescribed. Read More ›

Pharmacyclics, an AbbVie Company, together with Janssen Biotech, created a unique set of patient support programs called YOU&i Support. This is a personalized program that helps patients to access Imbruvica (ibrutinib), a Bruton kinase inhibitor; find affordability support options; and sign up for information and resources to support them during their treatment. Read More ›

Puma Biotechnology, through its Puma Patient Lynx, provides a complete support services package for patients who have been prescribed Nerlynx (neratinib), to facilitate easy access and affordability. Read More ›

Regeneron Pharmaceuticals (and Sanofi Genzyme), through Libtayo Surround, offer a wide range of patient support and access services to eligible patients who have been prescribed Libtayo (cemiplimab-rwlc) injection. Read More ›

Page 1 of 3

Subscribe to
Oncology Practice Management

Stay up to date with oncology news & updates by subscribing to recieve the free OPM print publications or weekly e‑Newsletter.

I'd like to recieve: